The year in heart failure: 2004

Journal of Cardiac Failure

Volumn 11, Issue 1, 2005, Pages 1-6

  Massie, Barry M ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; AMIODARONE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM SENSITIZER; CARVEDILOL; CELECOXIB; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; ENALAPRIL; FUROSEMIDE; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; INOTROPIC AGENT; LEVOSIMENDAN; NEBIVOLOL; NESIRITIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PERINDOPRIL; ROFECOXIB; TOLVAPTAN; VASOPRESSIN V2 RECEPTOR; WARFARIN;

BLOOD SMEAR; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; DEFIBRILLATOR; DEVICE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; HEALTH CARE COST; HEART FAILURE; HEART LEFT VENTRICLE; HEART TRANSPLANTATION; HEMODYNAMIC MONITORING; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MITRAL VALVE REPLACEMENT; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; SODIUM RETENTION; STROKE; SURGICAL TECHNIQUE; SURVIVAL; SYMPTOM;

EID: 13444249770     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2005.01.001     Document Type: Editorial

References (31)

1. B.M. Massie 2003: The year in heart failure J Card Fail 10 2004 1 3
2. Bardy G. The Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Presented at the Annual Scientific Session of the American College of Cardiology. March 7-10, 2004. New Orleans, LA.
3. th Scientific Session of the American Heart Association. November 7-10 2004. New Orleans, LA.
4. A.L. Taylor, S. Ziesche, and C. Yancy Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 1049 1057
5. M.G. Bloche Race-based therapeutics N Engl J Med 351 2004 2035 2037
6. th Scientific Session of the American Heart Association. November 7-10 2004. New Orleans, LA.
7. B.M. Massie, W.F. Krol, and S.E. Ammon The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics J Card Fail 10 2004 101 112
8. Massie BM. The Warfarin and Antiplatelet Trial in Chronic Heart Failure (WATCH) trial. Presented at the Annual Scientific Session of the American College of Cardiology. March 7-10, 2004. New Orleans, LA.
9. J.G.F. Cleland, I. Findlay, and S. Jafri The Warfarin/Aspirin Study in Heart Failure (WASH): A randomized trial comparing antithrombotic strategies for patients with heart failure Am Heart J 148 2004 157 164
10. A.D. Galbreath, R.A. Krasuski, and B. Smith Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure Circulation 110 2004 3518 3526
11. R.F. DeBusk, N.H. Miller, and K.M. Parker Care management for low-risk patients with heart failure: a randomized, controlled trial Ann Intern Med 141 2004 606 613
12. F.A. McAlister, S. Steward, S. Ferrua, and J.J. McMurray Multidisciplinary strategies for the management of heart failure patients at risk for admission: as systematic review of randomized trials J Am Coll Cardiol 44 2004 810 819
13. F.H. Gwadry-Sridhar, V. Flintoft, D.S. Lee, H. Lee, and G.H. Guyatt A systematic review and meta-analysis of studies comparing readmission rates and mortality rates in patients with heart failure Arch Intern Med 164 2004 2315 2320
14. D.L. Mann, M.A. Acker, M. Jessup, H.N. Sabbah, R.C. Starling, and S.H. Kubo Rationale, design, and methods for a pivotal randomized clinical trial for the assessment of a cardiac support device in patients with New York health association class III-IV heart failure J Card Fail 10 2004 185 192
15. th Scientific Session of the American Heart Association. November 7-10 2004. New Orleans, LA.
16. Coats AJ. The Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with Heart Failure (SENIORS). Presented at the European Society of Cardiology Congress. August 29, 2004. Munich, Germany.
17. H. Krum, E.B. Roecker, and P. Mohacsi Effects of initiating carvedilol in patients with severe chronic heart failure. Results from the COPERNICUS study JAMA 289 2003 712 718
18. W.A. Gattis, C.M. O'Connor, D.S. Gallup, V. Hasselblad, and M. Gheorghiade Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Processes for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial J Am Coll Cardiol 43 2004 1534 1541
19. K. Sliwa, G.R. Norton, and N. Kone Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure J Am Coll Cardiol 44 2004 1825 1830
20. D.M. McNamara, R. Holubkov, and L. Postava Pharmocogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure J Am Coll Cardiol 44 2004 2019 2026
21. D.M. Kaye, B. Smirk, S. Finch, C. Williams, and M.D. Esler Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype J Am Coll Cardiol 44 2004 2008 2015
22. C.C. Liew, and V.J. Dzau Molecular genetics and genomics of heart failure Nat Rev Genet 5 2004 811 825
23. M.R. Taylor, and M.R. Bristow The emerging pharmacogenomics of the beta-adrenergic receptors Congest Heart Fail 1 2004 281 288
24. M.G. Shlipak, and B.M. Massie The clinical challenge of cardiorenal syndrome Circulation 110 2004 1514 1517
25. U. Elkayam, G. Tasissa, and C. Binanay Use and impact of inotropes and vasodilator therapy during heart failure hospitalization in the ESCAPE trial (abstract) Circulation 110 Suppl III 2004 III-515
26. D.J. Wang, T.C. Dowling, and D. Meadows Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine Circulation 110 2004 Sep 21 1620 1625
27. J.D. Sackner-Bernstein, H. Skopicki, and K.D. Aronson Is nesiritide associated with renal injury in patients with acutely decompensated heart failure (abstract) Circulation 110 Suppl III 2004 III-515
28. M.N. Zairis, C. Apostolatos, and P. Anastasiadis The effective of a calcium sensitizer or an inotrope or none in chronic low output decompensated heart failure: Results from the calcium sensitizer or inotrope or none in low output heart failure study (CASINO). Abstract J Am Coll Cardiol 43 Suppl A 2004 206A
29. F. Follath, J.G. Cleland, and H. Just Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial Lancet 360 9328 2002 Jul 20 196 202
30. M. Gheorghiade, W.A. Gattis, and C.M. O'Connor Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure. A randomized controlled trial JAMA 291 2004 1963 1971
31. M. Mamdani, D.N. Jurrlink, and D.S. Lee Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal antiinflammatory drugs and congestive heart failure outcomes in elderly patients: a population based cohort study Lancet 363 2004 1751 1756